{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:22:31Z","timestamp":1788459751738,"version":"build-2803163510"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hemophagocytic syndrome (HPS) is a potentially life-threatening complication of systemic inflammatory disorders. Adult-onset Still disease (AOSD) is one of the systemic autoimmune diseases associated with reactive hemophagocytic syndrome (RHS). This study aimed to evaluate the characteristic findings, predictive factors, and prognosis of RHS in patients with AOSD.<\/jats:p>\n                    <jats:p>We retrospectively evaluated 109 patients diagnosed with AOSD and reviewed their clinical data and laboratory findings, including the biopsy results of 21 AOSD patients with RHS. Moreover, data from 17 hemophagocytic lymphohistiocytosis (HLH) patients evaluated during the same period were compared with those from the RHS patients.<\/jats:p>\n                    <jats:p>\n                      Twenty-one patients (19.3%) developed RHS during the course of AOSD, and only 7 patients (6.4%) were confirmed by bone marrow, liver, or lymph node biopsy. AOSD patients with RHS showed significantly higher frequencies of splenomegaly, hepatomegaly, and lymphadenopathy than did those without RHS. Moreover, patients with RHS showed significantly higher relapse rates than those without RHS (61.9% vs 18.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Possible triggering factors inducing hemophagocytosis were detected in 16 of 21 RHS patients (76.2%): disease flare in 12 patients (75%), infection in 3 patients (18.8%), and drug use in 1 patient (6.3%). AOSD patients with RHS showed higher frequencies of leukopenia, anemia, thrombocytopenia, hypoalbuminemia, hypofibrinogenemia, hypertriglyceridemia, hyperferritinemia, and elevated lactate dehydrogenase levels than did those without RHS. Multivariate logistic regression with forward selection procedure showed that low platelet count (&lt;121,000\/mm\n                      <jats:sup>3<\/jats:sup>\n                      ), anemia, and hepatomegaly were independent predictors of RHS. Patients with definite RHS and those with probable RHS showed comparable results. Although RHS is a life-threatening complication of AOSD, long-term prognosis was observed to be similar in patients with and those without RHS. Compared to RHS patients, HLH patients had poor prognosis, such as higher death rates (52.9% vs 9.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a0.005).\n                    <\/jats:p>\n                    <jats:p>RHS can be considered when an AOSD patient shows at least 2 of the following 3 findings: low platelet count, anemia, and hepatomegaly. Diagnostic confirmation by biopsy may not be essential if typical clinical findings of RHS are present. Moreover, prognosis of RHS was better than that of HLH diagnosed by the presence of trilineage cytopenia at admission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000000451","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T02:05:49Z","timestamp":1422497149000},"page":"e451","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":73,"title":["Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease"],"prefix":"10.1097","volume":"94","author":[{"given":"Chang-Bum","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20260903","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"R2-22-20260903","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndrome","volume":"21","author":"Janka","year":"2007","journal-title":"Blood Rev"},{"key":"R3-22-20260903","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00002281-200209000-00012","article-title":"Macrophage activation syndrome","volume":"14","author":"Ravelli","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"R4-22-20260903","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","article-title":"Pathogenesis of hemopahgocytic syndrome","volume":"3","author":"Larroche","year":"2004","journal-title":"Autoimmun Rev"},{"key":"R5-22-20260903","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOH.0b013e3282f97f88","article-title":"Whem T cells and macrophage do not talk: the hemophagocytic syndrome","volume":"15","author":"Arceci","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"R6-22-20260903","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/BOR.0b013e32834dd37e","article-title":"Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndrome","volume":"24","author":"Canna","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R7-22-20260903","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-5710(97)00584-7","article-title":"Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment","volume":"66","author":"Imashuku","year":"1997","journal-title":"Int J Hematol"},{"key":"R8-22-20260903","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R9-22-20260903","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","article-title":"Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?","volume":"15","author":"Grom","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"R10-22-20260903","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation","volume":"10","author":"Castillo","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R11-22-20260903","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.11368","article-title":"Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review","volume":"49","author":"Dhote","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R12-22-20260903","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/s10165-004-0293-6","article-title":"Autoimmune-associated hemophagocytic syndrome","volume":"14","author":"Kumakura","year":"2004","journal-title":"Mod Rheumatol"},{"key":"R13-22-20260903","first-page":"RA27","article-title":"Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases","volume":"14","author":"Tristano","year":"2008","journal-title":"Med Sci Monit"},{"key":"R14-22-20260903","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"Fukaya","year":"2008","journal-title":"Rheumatology (Oxford"},{"key":"R15-22-20260903","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","article-title":"Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases","volume":"31","author":"Lin","year":"2012","journal-title":"Clin Rheumatol"},{"key":"R16-22-20260903","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"Stephan","year":"2001","journal-title":"Rheumatology (Oxford"},{"key":"R17-22-20260903","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"R18-22-20260903","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical feature and long-term outcome: a case-conrol study of 8 patients","volume":"89","author":"Hot","year":"2010","journal-title":"Medicine (Baltimore"},{"key":"R19-22-20260903","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00296-008-0825-z","article-title":"Cloak and dagger: the case for adult onset Still disease and hemophagocytic lymphohistiocytosis","volume":"29","author":"Felix","year":"2009","journal-title":"Rheumatol Int"},{"key":"R20-22-20260903","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R21-22-20260903","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00296-010-1497-z","article-title":"Hemophagocytic syndrome in adult-onset Still's disease (AOSD): a must for biologics? Case report and brief review of the literature","volume":"32","author":"Burgi","year":"2012","journal-title":"Rheumatol Int"},{"key":"R22-22-20260903","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1756-185X.2011.01691.x","article-title":"A case of adult-onset Still's disease complicated by hemophagocyti syndrome and interstitial pneumonia with pneumomediastium\/recurrent pneumonia","volume":"15","author":"Fujii","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"R23-22-20260903","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10067-006-0238-x","article-title":"Hemophagocytic syndrome in one patient with adult onset Still's disease: presentation with febrile neutropenia","volume":"26","author":"Pamuk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R24-22-20260903","first-page":"160","article-title":"Two cases of adult onset Still's disease with comcomitant hemophagocytic syndrome","volume":"14","author":"Kim","year":"2007","journal-title":"J Rheum Dis"},{"key":"R25-22-20260903","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"R26-22-20260903","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore"},{"key":"R27-22-20260903","first-page":"1027","article-title":"High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation","volume":"30","author":"Lambotte","year":"2003","journal-title":"J Rheumatol"},{"key":"R28-22-20260903","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","article-title":"Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation","volume":"42","author":"Wulffraat","year":"2003","journal-title":"Rheumatology (Oxford"},{"key":"R29-22-20260903","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R30-22-20260903","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.20198","article-title":"Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?","volume":"50","author":"Grom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R31-22-20260903","first-page":"100","article-title":"Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease","volume":"23","author":"Amenomori","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R32-22-20260903","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/15513819209023280","article-title":"Histiocytes in familial and infection-induced\/idiopathic hemophagocytic syndromes may exhibit phenotypic differences","volume":"12","author":"Buckley","year":"1992","journal-title":"Pediatr Pathol"},{"key":"R33-22-20260903","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R34-22-20260903","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.24883","article-title":"Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients","volume":"60","author":"Parodi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R35-22-20260903","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pbc.21441","article-title":"The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Gupta","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R36-22-20260903","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","article-title":"Modern management of children with haemophagocytic lymphohistiocytosis","volume":"124","author":"Janka","year":"2004","journal-title":"Br J Haematol"},{"key":"R37-22-20260903","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajh.1141","article-title":"Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes","volume":"68","author":"Emmenegger","year":"2001","journal-title":"Am J Hematol"},{"key":"R38-22-20260903","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/s10165-007-0006-z","article-title":"Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome","volume":"18","author":"Takahashi","year":"2008","journal-title":"Mod Rheumatol"},{"key":"R39-22-20260903","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.20462","article-title":"Success with infl iximab in treating refractory hemophagocytic lymphohistiocytosis","volume":"81","author":"Henzan","year":"2006","journal-title":"Am J Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005792-201501040-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:00:11Z","timestamp":1788458411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201501040-00022"}},"subtitle":["Clinical Features, Predictive Factors, and Prognosis in 21 Patients"],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000451","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}